PNKP and cancer: While this inhibitor has been previously reported as a potent and selective for PNKP, with an IC50 of ∼60 nM in several human cancer cell lines [27,28], our findings show it to be less effective, exhibiting an apparent IC50 of ∼20 μM (Fig. S1H) in multiple TNBC cell lines.